Desoximetasone Patent Expiration
Desoximetasone is Used for treating plaque psoriasis in patients 18 years of age or older. It was first introduced by Taro Pharmaceutical Industries Ltd
Desoximetasone Patents
Given below is the list of patents protecting Desoximetasone, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Topicort | US8277780 | Stable liquid desoximethasone compositions with reduced oxidized impurity | Sep 01, 2028 | Taro |
Topicort | US8715624 | Stable liquid desoximethasone compositions with reduced oxidized impurity | May 26, 2026 | Taro |
Topicort | US5990100 | Composition and method for treatment of psoriasis |
Mar 24, 2018
(Expired) | Taro |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Desoximetasone's patents.
Latest Legal Activities on Desoximetasone's Patents
Given below is the list recent legal activities going on the following patents of Desoximetasone.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 12th Year, Large Entity | 02 Apr, 2024 | US8277780(Litigated) |
Payment of Maintenance Fee, 8th Year, Large Entity | 08 Nov, 2021 | US8715624(Litigated) |
Payment of Maintenance Fee, 8th Year, Large Entity | 02 Apr, 2020 | US8277780(Litigated) |
Payment of Maintenance Fee, 4th Year, Large Entity | 27 Oct, 2017 | US8715624(Litigated) |
Change in Power of Attorney (May Include Associate POA) Critical
| 09 Mar, 2017 | US8715624(Litigated) |
Email Notification Critical
| 09 Mar, 2017 | US8715624(Litigated) |
Email Notification Critical
| 07 Mar, 2017 | US8277780(Litigated) |
Change in Power of Attorney (May Include Associate POA) Critical
| 07 Mar, 2017 | US8277780(Litigated) |
Correspondence Address Change Critical
| 07 Mar, 2017 | US8715624(Litigated) |
Correspondence Address Change Critical
| 06 Mar, 2017 | US8277780(Litigated) |
Desoximetasone's Family Patents
